Antitumor composition, expression vector for same and application of antitumor composition
An anti-tumor drug and composition technology, applied in the biological field, can solve the problem of insufficient number of local T cells in tumors, and achieve the effects of promoting anti-tumor immune response, prolonging survival, and inhibiting tumor growth
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Example 1: Preparation and identification of recombinant vectors and transfected cell lines that stably secrete IL-36γ and sPD-1 genes
[0042] Design a fusion gene fragment containing the human CD8 signal peptide sequence and the fully active murine IL-36γ fragment (G13~S164) coding region, and design a fusion gene fragment containing the human CD8 signal peptide sequence and the mouse PD-1 extracellular functional region (G13~S164). S164) fusion gene fragments of the coding region were respectively synthesized and inserted into the eukaryotic expression vector pCDEF3 to construct recombinant expression vectors pCDEF3-IL-36γ and pCDEF3-sPD-1. The mouse melanoma cell line B16 was transfected with pCDEF3-IL-36γ and pCDEF3-sPD-1 respectively or jointly with liposomes, and was screened by G418, subcloned and identified by QRT-PCR and ELISA. 36γ, sPD-1 and gene transfected cell lines B16-IL-36γ, B16-sPD-1, B16-IL-36γ / sPD-1 ( figure 1 A and 1B). At the same time, the empty...
Embodiment 2
[0043] Example 2: IL-36γ combined with sPD-1 significantly synergistically inhibits tumor growth and prolongs the survival of tumor-bearing mice
[0044] The gene transfection cell lines B16-vec, B16-sPD-1, B16-IL-36γ and B16-IL-36γ / sPD-1 successfully constructed in Example 1 were subcutaneously inoculated into C57BL / 6 mice in the abdomen, and every 2 The tumor size of the mice was measured and the survival of the mice was observed.
[0045] The results showed that compared with the control group B16-vec, sPD-1 secreted and expressed by B16-sPD-1 did not significantly inhibit tumor growth, and IL-36γ secreted and expressed by B16-IL-36γ could significantly inhibit tumor growth. When B16-IL-36γ / sPD-1 co-expressed IL-36γ and sPD-1, tumor growth was further significantly inhibited ( figure 2 A), showing that IL-36γ combined with sPD-1 has a synergistic inhibitory effect on tumor growth. At the same time, the observation of the survival period of tumor-bearing mice showed that ...
Embodiment 3
[0046] Example 3: IL-36γ combined with sPD-1 has a synergistic effect on the anti-tumor immune response in the early tumor microenvironment
[0047] The transfected cell lines B16-vec, B16-sPD-1, B16-IL-36γ and B16-IL-36γ / sPD-1 were subcutaneously inoculated into C57BL / 6 mice in the abdomen respectively. Infiltrating lymphocytes in the microenvironment of tumors (day 25 of tumor growth) and their functions were analyzed.
[0048] (1) Compared with B16-vec, B16-sPD-1, B16-IL-36γ in the control group, in B16-IL-36γ / sPD-1 tumors: the proportion of CD4+ T cell population was significantly increased ( image 3 ); CD4 in tumor + and CD8 + T cell nuclear proliferation antigen was significantly up-regulated ( Figure 4 and Figure 5 ); CD4 in tumor + and CD8 + The function of T cells is promoted, and the expression level of IFN-γ in these two groups of T cells is significantly increased and the expression level of CD107a in CD8 + The expression level on T cells was significantl...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com